However, researchers cautioned, “Benefits of statins in reducing cardiovascular events clearly overwhelm the diabetes risk.”
The researchers looked at data on 115,709 Italians who started a statin in 2003 or 2004. The researchers kept track of how many patients developed diabetes until 2010. During the study, 11,154 patients started using an anti-diabetes medication or were hospitalized with a diagnosis of type-2 diabetes.
Researchers found that diabetes was more common in patients who strictly adhered to the dosing regimen compared to patients who took less than 25% of the pills they were prescribed. Essentially, higher doses translated into higher rates of diabetes:
- Low adherence (26-50%): 12% increased risk of diabetes
- Intermediate adherence (51-75%): 22% increased risk of diabetes
- High adherence (75%+): 32% increased risk of diabetes.
The study adds to a growing body of evidence linking high doses of statins with higher rates of diabetes. Last month, a study published in the British Medical Journal found that patients on high-potency statins were 15% more likely to develop new-onset diabetes within two years, compared to patients on low-potency statins. Hundreds of lawsuits are now pending against Pfizer, the manufacturer of Lipitor, from people who allege that the drug-maker did not adequately warn about the risk.
Need a Texas Lipitor Lawyer?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas Lipitor lawyers for a free lawsuit review.